help button home button Am J Pathol Epitomics, Inc.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Dijk, J. P.
Right arrow Articles by Jansen, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Dijk, J. P.
Right arrow Articles by Jansen, J. H.
(American Journal of Pathology. 2002;161:807-812.)
© 2002 American Society for Investigative Pathology

Technical Advance

A Novel, Essential Control for Clonality Analysis with Human Androgen Receptor Gene Polymerase Chain Reaction

Jeroen P. van Dijk*, Leonie H. Heuver*, Bert A. van der Reijden*, Reinier A. Raymakers{dagger}, Theo de Witte{dagger} and Joop H. Jansen*

From the Central Hematology Laboratory* and the Department of Hematology,{dagger} University Medical Center Nijmegen, The Netherlands

The most widely used technique for determining clonality based on X-chromosome inactivation is the human androgen receptor gene polymerase chain reaction (PCR). The reliability of this assay depends critically on the digestion of DNA before PCR with the methylation-sensitive restriction enzyme HpaII. We have developed a novel method for quantitatively monitoring the HpaII digestion in individual samples. Using real-time quantitative PCR we measured the efficiency of HpaII digestion by measuring the amplification of a gene that escapes X-chromosome inactivation (XE169) before and after digestion. This method was tested in blood samples from 30 individuals: 2 healthy donors and 28 patients with myelodysplastic syndrome. We found a lack of XE169 DNA reduction after digestion in the granulocytes of two myelodysplastic syndrome patients leading to a false polyclonal X-chromosome inactivation pattern. In all other samples a significant reduction of XE169 DNA was observed after HpaII digestion. The median reduction was 220-fold, ranging from a 9.0-fold to a 57,000-fold reduction. Also paraffin-embedded malignant tissue was investigated from two samples of patients with mantle cell lymphoma and two samples of patients with colon carcinoma. In three of these cases inefficient HpaII digestion led to inaccurate X-chromosome inactivation pattern ratios. We conclude that monitoring the efficiency of the HpaII digestion in a human androgen receptor gene PCR setting is both necessary and feasible.




This article has been cited by other articles:


Home page
 J. Mol. Diagn.Home page
M. Boudewijns, J. J.M. van Dongen, and A. W. Langerak
The Human Androgen Receptor X-Chromosome Inactivation Assay for Clonality Diagnostics of Natural Killer Cell Proliferations
J. Mol. Diagn., July 1, 2007; 9(3): 337 - 344.
[Abstract] [Full Text] [PDF]

Home page
 Neuro OncologyHome page
A. Pandita, A. Balasubramaniam, R. Perrin, P. Shannon, and A. Guha
Malignant and benign ganglioglioma: A pathological and molecular study
Neuro Oncology, April 1, 2007; 9(2): 124 - 134.
[Abstract] [Full Text] [PDF]

Home page
 J Gerontol A Biol Sci Med SciHome page
W.-Y. Au, V. Lam, A. Pang, W.-M. Lee, J. L. C. Chan, Y.-Q. Song, E. S. Ma, and Y.-L. Kwong
Glucose-6-Phosphate Dehydrogenase Deficiency in Female Octogenarians, Nanogenarians, and Centenarians
J Gerontol A Biol Sci Med Sci, October 1, 2006; 61(10): 1086 - 1089.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the American Society for Investigative Pathology.